Medscape

NOR-TEST: Tenecteplase Similar to Alteplase in Stroke

PRAGUE, Czech Republic — A 0.4-mg/kg bolus dose of tenecteplase (TNKase, Genentech) was associated with functional outcomes and safety similar to those seen with the standard of care, alteplase ...
Healio

Reteplase may be viable, less costly alternative vs. alteplase for treatment of stroke

Please provide your email address to receive an email when new articles are posted on . In a phase 2 study, reteplase demonstrated similar efficacy and safety vs. alteplase for the treatment of acute ...
MedPage Today

Making Low-Dose tPA Work for Japanese DOAC Users With Ischemic Stroke

Despite concerns about the potential bleeding risk, IV thrombolysis could be safely given to ischemic stroke patients within a day of direct oral anticoagulant (DOAC) therapy, according to ...
MedPage Today

Tenecteplase on Par With Alteplase, Randomized Trial Affirms

DALLAS -- Tenecteplase (TNKase) did as good a job at ischemic stroke thrombolysis as did alteplase (Activase) for patients presenting within 4.5 hours of symptom onset in the randomized TRACE-2 trial ...
Medscape

Intra-arterial Alteplase Shows Functional Gains After Thrombectomy

Intra-arterial (IA) alteplase was associated with superior 90-day functional outcomes than standard therapy alone in Chinese patients with large-vessel occlusion (LVO) stroke who had achieved ...